FDA Convenes Hearing on Pain-Pill Labels

Published February 11, 2013

FDA Convenes Hearing on Pain-Pill Labels
… are fueling an epidemic of addiction and overdose deaths. The agency is considering a petition by a group of 35 doctors and pain specialists to include a recommended upper daily dose on the drugs' label and limit the duration of opioid treatment to … Read more on Wall Street Journal

Disulfiram: New support for an old addiction drug
Thus, pharmacogenetic matching is critical for the optimal efficacy of disulfiram in cocaine addiction, and this matching includes the majority of these patients." Disulfiram is not an FDA-approved treatment for cocaine addiction, and in fact, there … Read more on EurekAlert (press release)